Literature DB >> 2881877

Localization and cloning of Xp21 deletion breakpoints involved in muscular dystrophy.

A P Monaco, C J Bertelson, C Colletti-Feener, L M Kunkel.   

Abstract

Twenty-nine deletion breakpoints were mapped in 220 kb of the DXS164 locus relative to potential exons of the Duchenne and Becker muscular dystrophy gene. Four deletion junction fragments were isolated to acquire outlying Xp21 loci on both the terminal and centromere side of the DXS164 locus. The junction loci were used for chromosome walking, searches for DNA polymorphisms, and mapping against deletion and translocation breakpoints. Forty-four unrelated deletions were analyzed using the junction loci as hybridization probes to map the endpoints between cloned Xp21 loci. DNA polymorphisms from the DXS164 and junction loci were used to follow the segregation of a mutation in a family that represents a recombinant. Both the physical and genetic data point to a very large size for this X-linked muscular dystrophy locus.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2881877     DOI: 10.1007/bf00281063

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

1.  Electrophoretic separations of large DNA molecules by periodic inversion of the electric field.

Authors:  G F Carle; M Frank; M V Olson
Journal:  Science       Date:  1986-04-04       Impact factor: 47.728

2.  A strategy to reveal high-frequency RFLPs along the human X chromosome.

Authors:  J Aldridge; L Kunkel; G Bruns; U Tantravahi; M Lalande; T Brewster; E Moreau; M Wilson; W Bromley; T Roderick
Journal:  Am J Hum Genet       Date:  1984-05       Impact factor: 11.025

3.  Lambda replacement vectors carrying polylinker sequences.

Authors:  A M Frischauf; H Lehrach; A Poustka; N Murray
Journal:  J Mol Biol       Date:  1983-11-15       Impact factor: 5.469

4.  Separation of yeast chromosome-sized DNAs by pulsed field gradient gel electrophoresis.

Authors:  D C Schwartz; C R Cantor
Journal:  Cell       Date:  1984-05       Impact factor: 41.582

5.  Molecular heterogeneity of translocations associated with muscular dystrophy.

Authors:  Y Boyd; E Munro; P Ray; R Worton; T Monaco; L Kunkel; I Craig
Journal:  Clin Genet       Date:  1987-04       Impact factor: 4.438

6.  Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes.

Authors:  R G Worton; C Duff; J E Sylvester; R D Schmickel; H F Willard
Journal:  Science       Date:  1984-06-29       Impact factor: 47.728

Review 7.  Construction of a genetic linkage map in man using restriction fragment length polymorphisms.

Authors:  D Botstein; R L White; M Skolnick; R W Davis
Journal:  Am J Hum Genet       Date:  1980-05       Impact factor: 11.025

8.  Isolation of candidate cDNAs for portions of the Duchenne muscular dystrophy gene.

Authors:  A P Monaco; R L Neve; C Colletti-Feener; C J Bertelson; D M Kurnit; L M Kunkel
Journal:  Nature       Date:  1986 Oct 16-22       Impact factor: 49.962

9.  Genetic analysis of the proximal portion of the mouse t complex: evidence for a second inversion within t haplotypes.

Authors:  B Herrmann; M Bućan; P E Mains; A M Frischauf; L M Silver; H Lehrach
Journal:  Cell       Date:  1986-02-14       Impact factor: 41.582

10.  A physical map of 4 million bp around the Duchenne muscular dystrophy gene on the human X-chromosome.

Authors:  G J van Ommen; J M Verkerk; M H Hofker; A P Monaco; L M Kunkel; P Ray; R Worton; B Wieringa; E Bakker; P L Pearson
Journal:  Cell       Date:  1986-11-21       Impact factor: 41.582

View more
  45 in total

1.  A 230kb cosmid walk in the Duchenne muscular dystrophy gene: detection of a conserved sequence and of a possible deletion prone region.

Authors:  R Heilig; C Lemaire; J L Mandel
Journal:  Nucleic Acids Res       Date:  1987-11-25       Impact factor: 16.971

2.  Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations.

Authors:  E Bakker; H Veenema; J T Den Dunnen; C van Broeckhoven; P M Grootscholten; E J Bonten; G J van Ommen; P L Pearson
Journal:  J Med Genet       Date:  1989-09       Impact factor: 6.318

3.  Molecular analysis of aberrations of Xp and Yq.

Authors:  S D Cheng; R Gasparini; U Müller
Journal:  Hum Genet       Date:  1992-02       Impact factor: 4.132

4.  Germinal mosaicism and risk calculation in X-linked diseases.

Authors:  M Jeanpierre
Journal:  Am J Hum Genet       Date:  1992-05       Impact factor: 11.025

5.  Molecular genetic analysis of factor X deficiency: gene deletion and germline mosaicism.

Authors:  K Wieland; D S Millar; C B Grundy; R S Mibashan; V V Kakkar; D N Cooper
Journal:  Hum Genet       Date:  1991-01       Impact factor: 4.132

6.  An informative polymorphism detectable by polymerase chain reaction at the 3' end of the dystrophin gene.

Authors:  C Oudet; R Heilig; J L Mandel
Journal:  Hum Genet       Date:  1990-02       Impact factor: 4.132

Review 7.  Improved diagnosis of Duchenne/Becker muscular dystrophy.

Authors:  A H Beggs; L M Kunkel
Journal:  J Clin Invest       Date:  1990-03       Impact factor: 14.808

8.  Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA.

Authors:  B T Darras; U Francke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

9.  Localization of the gene for X-linked recessive type of retinitis pigmentosa (XLRP) to Xp21 by linkage analysis.

Authors:  M A Musarella; A Burghes; L Anson-Cartwright; M M Mahtani; R Argonza; L C Tsui; R Worton
Journal:  Am J Hum Genet       Date:  1988-10       Impact factor: 11.025

10.  Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations.

Authors:  B T Darras; P Blattner; J F Harper; A J Spiro; S Alter; U Francke
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.